Bladder cancer, Transitional cell cancer
Results
Phase 1
This trial looked at cetuximab alongside radiotherapy and chemotherapy for bladder cancer that has grown into the muscle layer. This is called invasive bladder cancer.
The trial was supported by Cancer Research UK. It was open for people to join between 2012 and 2016. The team published the results in 2022.
Recruitment start: 10 September 2012
Recruitment end: 31 October 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nick James
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Merck Serono UK
NIHR Clinical Research Network: Cancer
University of Birmingham
This is Cancer Research UK trial number CRUK/09/021.
Last reviewed: 10 January 2023
CRUK internal database number: 3872
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
